Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA)-Experienced Adults with Type 2 Diabetes (T2D) Switching to Once-Weekly (OW) Semaglutide in a Real-World Setting-SURE Program Post Hoc Analysis

被引：0
|
作者：
Rudofsky, Gottfried
Menzen, Markus
Potier, Louis
Catarig, Andrei-Mircea
Clark, Alice
Priyadarshini, Prachi
Abreu, Cristina
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-76-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
76-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis
    Rudofsky, Gottfried
    Menzen, Markus
    Potier, Louis
    Catarig, Andrei-Mircea
    Clark, Alice
    Priyadarshini, Prachi
    Abreu, Cristina
    ADVANCES IN THERAPY, 2025, 42 (02) : 788 - 800
  • [2] Glucagon-like peptide-1 receptor agonist-experienced adults with type 2 diabetes switching to once-weekly semaglutide: post hoc analysis of the real-world SURE programme
    Rudofsky, G.
    Menzen, M.
    Potier, L.
    Catarig, A. -M.
    Clark, A.
    Priyadarshini, P.
    Abreu, C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S334 - S335
  • [3] Albiglutide: A once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus
    Davis, Portia N.
    Ndefo, Uche Anadu
    Oliver, Ashley
    Payton, Enryka
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (13) : 1097 - 1103
  • [4] GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1RA) AND UPPER ENDOSCOPY: A REAL WORLD EXPERIENCE
    Siranart, Noppachai
    Thompson, Christopher
    Jirapinyo, Pichamol
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB307 - AB307
  • [5] Once-weekly semaglutide use in glucagon-like peptide-1 receptor agonist naive patients with type 2 diabetes in North Macedonia: Real-world data from the MIRAGE study
    Milenkovikj, Tatjana
    Mitreva, Biljana Chekorova
    Mishevska, Sasha Jovanovska
    Bitoska-Mileva, Iskra
    Ahmeti, Irfan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 206
  • [6] Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population
    Hiep Nguyen
    Robert Dufour
    Amanda Caldwell-Tarr
    Advances in Therapy, 2017, 34 : 658 - 673
  • [7] PATIENT PREFERENCES FOR FREQUENCY OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1RA) INJECTIONS IN THE TREATMENT OF TYPE 2 DIABETES
    Hauber, A. B.
    Nguyen, H.
    Posner, J.
    Ervin, C. M.
    LaRue, S.
    Kalsekar, I
    VALUE IN HEALTH, 2014, 17 (03) : A255 - A255
  • [8] Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population
    Nguyen, Hiep
    Dufour, Robert
    Caldwell-Tarr, Amanda
    ADVANCES IN THERAPY, 2017, 34 (03) : 658 - 673
  • [9] Safety of once-weekly glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes
    Patel, Dhiren
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 : S29 - S42
  • [10] Safety of Once-weekly Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes
    Frias, Juan Pablo
    JOURNAL OF FAMILY PRACTICE, 2018, 67 (06): : S25 - S34
12345